|
| 31929001 | Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling. | Virology | 2020 |
| 30282735 | The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. | Proc Natl Acad Sci U S A | 2018 |
| 26749441 | High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission. | Cell Host Microbe | 2016 |
| 25322084 | Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. | ACS Chem Biol | 2015 |
| 26276895 | No robust evidence of lumefantrine resistance. | Antimicrob Agents Chemother | 2015 |
| 26081265 | The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine. | Expert Rev Anti Infect Ther | 2015 |
| 25984567 | A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein. | ACS Infect Dis | 2015 |
| 25568071 | Direct inhibitors of InhA are active against Mycobacterium tuberculosis. | Sci Transl Med | 2015 |
| 24366744 | KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. | Antimicrob Agents Chemother | 2014 |
| 25147620 | Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages. | ACS Med Chem Lett | 2014 |
| 24913172 | KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. | Antimicrob Agents Chemother | 2014 |
| 24090347 | Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents. | J Med Chem | 2013 |
| 24900693 | Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents. | ACS Med Chem Lett | 2013 |
| 24284631 | Targeting Plasmodium PI(4)K to eliminate malaria. | Nature | 2013 |
| 24307692 | Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. | Sci Transl Med | 2013 |
| 22524250 | Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. | J Med Chem | 2012 |
| 22500615 | A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis. | ACS Chem Biol | 2012 |
| 20813141 | Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. | Mol Biochem Parasitol | 2011 |
| 22096101 | Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. | Science | 2011 |
| 21644570 | Imidazolopiperazines: hit to lead optimization of new antimalarial agents. | J Med Chem | 2011 |
| 21502533 | Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). | Proc Natl Acad Sci U S A | 2011 |
| 20568778 | Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. | J Med Chem | 2010 |
| 21037109 | Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. | Proc Natl Acad Sci U S A | 2010 |
| 20975714 | A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. | Nat Commun | 2010 |
| 20610151 | Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials. | Bioorg Med Chem Lett | 2010 |
| 19879133 | Cell-based optimization of novel benzamides as potential antimalarial leads. | Bioorg Med Chem Lett | 2009 |
| 18579783 | In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. | Proc Natl Acad Sci U S A | 2008 |
| 18854154 | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | Cell | 2008 |
| 17035019 | 4-Aminopyrimidines as novel HIV-1 inhibitors. | Bioorg Med Chem Lett | 2007 |
| 17257639 | Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening. | Virology | 2007 |
| 16352537 | "UnPAKing" human immunodeficiency virus (HIV) replication: using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection. | J Virol | 2006 |
| 17092919 | Just-in-time purification: an effective solution for cherry-picking and purifying active compounds from large legacy libraries. | J Biomol Screen | 2006 |
| 16782337 | Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors. | Bioorg Med Chem Lett | 2006 |
| 16781149 | Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. | Bioorg Med Chem Lett | 2006 |
| 16480865 | Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I. | Bioorg Med Chem Lett | 2006 |
| 16464578 | Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2. | Bioorg Med Chem Lett | 2006 |
| 16632349 | Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1. | Bioorg Med Chem Lett | 2006 |
| 16093555 | Homogeneous high-throughput screening assays for HIV-1 integrase 3beta-processing and strand transfer activities. | J Biomol Screen | 2005 |
| 15542635 | Identification of cellular cofactors for human immunodeficiency virus replication via a ribozyme-based genomics approach. | J Virol | 2004 |
| 12696103 | Generation of dendritic cells from lentiviral vector-transduced CD34+ cells from HIV+ donors. | J Med Virol | 2003 |
| 11602580 | Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function. | J Biol Chem | 2001 |
| 10942374 | Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. | Blood | 2000 |
| 10544135 | Alternative splice variants of the human PKR protein kinase possessing different 5'-untranslated regions: expression in untreated and interferon-treated cells and translational activity. | Virology | 1999 |
| 10690406 | Lentivirus replication and regulation. | Annu Rev Genet | 1999 |
| 9927585 | Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. | Virology | 1999 |
| 9811730 | Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene. | J Virol | 1998 |
| 9007065 | Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes. | Virology | 1997 |
| 9114594 | The PKR protein kinase--an interferon-inducible regulator of cell growth and differentiation. | Int J Hematol | 1997 |
| 8812437 | Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. | Genomics | 1996 |
| 8921913 | Mechanism of interferon action sequence of the human interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones. | Gene | 1996 |